Brief: CK Life Sciences Intl Posts FY Profit Attributable HK$17.3 Mln
March 19 (Reuters) - CK Life Sciences Intl (Holdings)
Inc 0775.HK :
* FY PROFIT ATTRIBUTABLE HK$17.3 MILLION VERSUS HK$132.0
MILLION
* FY REVENUE HK$5.32 BILLION VERSUS HK$5.28 BILLION
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development